TY - JOUR
T1 - Infant gastroesophageal reflux disease management consensus
AU - Vandenplas, Yvan
AU - Orsi, Marina
AU - Benninga, Marc
AU - Gatcheco, Felizardo
AU - Rosen, Rachel
AU - Thomson, Mike
N1 - Funding Information: Medical writing support was provided by Luqman Khan of Connect Communications, Dubai, UAE and funded by Reckitt Benckiser, UK. The authors would like to thank Fiona Mclaughlin and Cathal Coyle of Reckitt Benckiser Health Limited, Medical Sciences, Hull, United Kingdom for supporting this initiative. Funding Information: This work, including medical writing support, was supported by Reckitt Benckiser, UK. Reckitt Benckiser was not involved in the consensus meeting or the development and approval of the final manuscript. Publisher Copyright: © 2023 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
PY - 2023
Y1 - 2023
N2 - Aim: Infant gastroesophageal reflux is mostly benign; however, when associated with complications like failure to thrive, it may be indicative of gastroesophageal reflux disease. There are currently several unmet needs pertaining to the management of infant gastroesophageal reflux (disease). Reflux in infants is mostly composed of breast milk or formula, so this population is significantly different to older children and adults. The objective of this Delphi consensus was to establish recommendations based on published literature and the experience of clinical experts in paediatric gastroenterology in the context of infant gastroesophageal reflux (disease). Methods: The Delphi methodology was used to obtain a consensus on 18 statements relating to clinical aspects of infant gastroesophageal reflux (disease). Results: The expert panel comprising paediatric gastroenterology clinical specialists reached a consensus for all statements by means of an online, anonymised voting system. Conclusion: It was highlighted that there is generally low awareness of or adherence to guidelines in clinical practice and that acid suppression therapy should not be indicated for non-acid reflux, which constitutes a significant proportion of total gastroesophageal reflux episodes among infants. Furthermore, it was emphasised that there is an unmet medical need for therapy for some symptomatic infants with non-acid reflux disease.
AB - Aim: Infant gastroesophageal reflux is mostly benign; however, when associated with complications like failure to thrive, it may be indicative of gastroesophageal reflux disease. There are currently several unmet needs pertaining to the management of infant gastroesophageal reflux (disease). Reflux in infants is mostly composed of breast milk or formula, so this population is significantly different to older children and adults. The objective of this Delphi consensus was to establish recommendations based on published literature and the experience of clinical experts in paediatric gastroenterology in the context of infant gastroesophageal reflux (disease). Methods: The Delphi methodology was used to obtain a consensus on 18 statements relating to clinical aspects of infant gastroesophageal reflux (disease). Results: The expert panel comprising paediatric gastroenterology clinical specialists reached a consensus for all statements by means of an online, anonymised voting system. Conclusion: It was highlighted that there is generally low awareness of or adherence to guidelines in clinical practice and that acid suppression therapy should not be indicated for non-acid reflux, which constitutes a significant proportion of total gastroesophageal reflux episodes among infants. Furthermore, it was emphasised that there is an unmet medical need for therapy for some symptomatic infants with non-acid reflux disease.
KW - consensus recommendations
KW - gastroesophageal reflux disease
KW - infant gastroenterology
KW - paediatrics
KW - vomiting
UR - http://www.scopus.com/inward/record.url?scp=85180250449&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/apa.17074
DO - https://doi.org/10.1111/apa.17074
M3 - Review article
C2 - 38116947
SN - 0803-5253
JO - Acta Paediatrica, International Journal of Paediatrics
JF - Acta Paediatrica, International Journal of Paediatrics
ER -